Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Justin Klein
AddedMar 31, 2024
UpdatedMay 31, 2026
Justin Klein

Justin Klein

Co-Founder, Vensana Capital

CrunchbaseLinkedIn

Justin Klein's Career

Vensana Capital
Vensana Capital

Minneapolis, MN, US

Co-Founder
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals

Malvern, PA, US

Board Member· Board
ChromaCode
ChromaCode

Carlsbad, CA, US

Board Member· Board
Relievant Medsystems
Relievant Medsystems

Edina, MN, US

Board Member· Board
Personal Genome Diagnostics
Personal Genome Diagnostics

Baltimore, MD, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Justin Klein's Career

Vensana Capital
Vensana Capital
Investment FirmInvestment Firm82018Minneapolis, MN, US
Co-Founder

Leadership at Vensana Capital

Kirk NielsenKirk NielsenCo-Founder
Michael AckermannMichael AckermannBoard Member
Tom WilderTom WilderBoard Member

Similar to Vensana Capital

Venn VenturesVenn VenturesDallas, TX, USest. 2016Venn VenturesDallas, TX, US · est. 2016

Venn Ventures: An early-stage venture firm dedicated to investing in innovative founders and teams.

Investment Firm3
Bioventures InvestorsBioventures InvestorsWellesley, MA, USest. 1998Bioventures InvestorsWellesley, MA, US · est. 1998

BioVentures Investors, LLC: A US-based venture capital firm specializing in life sciences and healthcare sectors.

Investment Firm12
Engage Venture PartnersEngage Venture PartnersMinneapolis, MN, USest. 2022Engage Venture PartnersMinneapolis, MN, US · est. 2022

Engage Venture Partners: A venture capital firm specializing in early-stage medtech investments.

Investment Firm4
Versant VenturesVersant VenturesSan Francisco, CA, USest. 1999Versant VenturesSan Francisco, CA, US · est. 1999

Versant Ventures: A leading healthcare investment firm, focusing on novel therapeutic biotechnology.

Investment Firm68
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals
Public$324.3M402002Malvern, PA, US
Board Member· Board

Leadership at PhaseBio Pharmaceuticals

Alex SapirAlex SapirBoard Member
Richard Van Den BroekRichard Van Den BroekBoard Member
Clay ThorpClay ThorpBoard Member
Jonathan MowJonathan MowCEO
Bill HumphriesBill HumphriesBoard Member
Caroline LoewyCaroline LoewyBoard Member

Similar to PhaseBio Pharmaceuticals

CiVi BiopharmaCiVi BiopharmaChevy Chase, MD, USBiopharmaceuticalsest. 2016CiVi BiopharmaChevy Chase, MD, US · est. 2016

CiVi Biopharma: A US-based biotech firm specializing in R&D for cardiovascular and metabolic diseases.

Public · $89M14
BridgeBio PharmaBridgeBio PharmaPalo Alto, CA, USGenetic Medicinesest. 2015BridgeBio PharmaPalo Alto, CA, US · est. 2015

Bridgebio Pharma, a US-based biotech firm, specializes in developing medicines for genetic diseases globally.

Public · $3.6B392
Kyntra BioKyntra BioSan Francisco, CA, USPharmaceuticalsest. 1993Kyntra BioSan Francisco, CA, US · est. 1993

FibroGen, Inc: A global, research-based pharmaceutical company in San Francisco, innovating treatments for unmet medical needs.

Public · $188M592
Longevity BiotechLongevity BiotechPhiladelphia, PA, USDrug Candidates, Therapeuticsest. 2010Longevity BiotechPhiladelphia, PA, US · est. 2010

Philadelphia-based Longevity Biotech develops Hybridtides, transformative products tackling medical challenges.

Angel · $1.9M6
ChromaCode
ChromaCode
Series D$94M492012Carlsbad, CA, US
Board Member· Board

Leadership at ChromaCode

Carol GallagherCarol GallagherBoard Member
Jenny YipJenny YipBoard Member
Axel SchererAxel SchererCo-Founder
Greg GoschGreg GoschCo-Founder
Alex DickinsonAlex DickinsonBoard Member
Mark McDonoughMark McDonoughCEO

Similar to ChromaCode

KromatidKromatidFort Collins, CO, USAssays, Reagentsest. 2007KromatidFort Collins, CO, US · est. 2007

US-based KromaTiD develops assays and reagents to advance understanding of genetic abnormalities and diseases.

Seed · $2M33
Chroma MedicineChroma MedicineCambridge, MA, USGenomic Medicinesest. 2021Chroma MedicineCambridge, MA, US · est. 2021

Chroma Medicine: Pioneering genomic medicines to revolutionize treatment of genetic diseases.

Series B · $260M137
CodettaCodettaDurham, NC, USBiotechnology, Platformest. 2021CodettaDurham, NC, US · est. 2021

Codetta Bio offers a multi-omic analysis platform for accelerated R&D of next-gen therapies, enhancing patient care.

Seed · $17M35
ChemeleonChemeleonNew York, USDiagnostics, Medical Devicesest. 2013ChemeleonNew York, US · est. 2013

Rapid, instrument-free diagnostic platform providing at-home and POC colorimetric assays.

Seed · $6.1M6
Relievant Medsystems
Relievant Medsystems
Public$273.6M592006Edina, MN, US
Board Member· Board

Leadership at Relievant Medsystems

Tyler BinneyTyler BinneyCEO
Kevin HykesKevin HykesBoard Member
Jason LettmannJason LettmannBoard Member
Samit PatelSamit PatelFounder
Brent AhrensBrent AhrensBoard Member

Similar to Relievant Medsystems

Relevium MedicalRelevium MedicalGalway, County Galway, IEPain Treatmentsest. 2019Relevium MedicalGalway, County Galway, IE · est. 2019

Innovative biopharmaceutical company providing superior pain treatments.

Public4
RaymedicaRaymedicaMinneapolis, MN, USMedical Devicesest. 1990RaymedicaMinneapolis, MN, US · est. 1990

Raymedica, Inc. is a medical device manufacturer, innovating surgical solutions for low back pain treatment worldwide.

Series A · $10M30
Intact MedicalIntact MedicalFramingham, MA, USMedical Devicesest. 2002Intact MedicalFramingham, MA, US · est. 2002

US-based Intact Medical Corp. develops minimally invasive systems.

Pre-Seed · $25.7M7
Channel MedsystemsChannel MedsystemsSan Francisco, CA, USMedical Devicesest. 2009Channel MedsystemsSan Francisco, CA, US · est. 2009

San Francisco-based Channel Medsystems develops and delivers non-invasive medical technology products.

Series A · $62.9M35
Personal Genome Diagnostics
Personal Genome Diagnostics
Series C$244.7M1792010Baltimore, MD, US
Board Member· Board

Leadership at Personal Genome Diagnostics

Doug WardDoug WardBoard Member
James (Jim) LaFranceJames (Jim) LaFranceBoard Member
Victor VelculescuVictor VelculescuCo-Founder
Luis DiazLuis DiazCo-Founder
Felix DawsonFelix DawsonBoard Member

Justin Klein's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Justin Klein

Greg KleinGreg KleinCo-Founder · Tartavull Klein Blatteis CapitalDavid KyleDavid KyleFounder · Advanced BionutritionBrian MonahanBrian MonahanCo-Founder · NewcoBruce ClevelandBruce ClevelandCo-Founder · Wildcat Venture PartnersDavid KleinDavid KleinCo-Founder · INSPECTORIONeil SteinhardtNeil SteinhardtCo-Founder · ClassWallet